Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data.

< BACK TO ARCHIVE


2020 Jan-Dec


J Prim Care Community Health


http://www.ncbi.nlm.nih.gov/pubmed/33095099?dopt=Abstract


11

Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data.

Authors

Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data.
Dodick DW, Shewale AS, Lipton RB, Baum SJ, Marcus SC, Silberstein SD, Pavlovic JM, Bennett NL, Young WB, Viswanathan HN, Doshi JA, Weintraub H
J Prim Care Community Health. 2020 Jan-Dec; 11:2150132720963680.
PMID: 33095099.

Abstract

Triptans, the most commonly prescribed acute treatments for migraine attacks are, per FDA labeling, contraindicated in cardiovascular (CV) disease patients and have warnings and precautions for those with CV risk factors.
Read This Paper